RENXF'ün son EPS'si beklentilerle karşılaştırıldığında nasıldı?
Renalytix PLC RENXF'ün son çeyrekteki geliri nasıl performans gösterdi?
Renalytix PLC'in gelir tahmini nedir?
Renalytix PLC'in kazanç kalite puanı nedir?
Renalytix PLC kazançlarını ne zaman rapor eder?
Renalytix PLC'in beklenen kazançları nelerdir?
Renalytix PLC kazanç beklentilerini aştı mı?
Önemli İstatistikler
Önceki Kapanış
$0.163
Açılış fiyatı
$0.163
Günün Aralığı
$0.163 - $0.163
52 haftalık aralık
$0.06 - $0.179
İşlem hacmi
31
Ort.Hacim
8
EPS (TTM)
-0.07
Dividend yield
--
Piyasa Değeri
$71.2M
RENXF nedir?
Renalytix Plc engages in the manufacturing of medical devices and equipment. The firm is engaged in a field of bioprognosis for kidney health. The firm has engineered a solution that enables early-stage chronic kidney disease progression risk assessment. KidneyIntelX, is a vitro diagnostic platform, employs a proprietary algorithm that combines diverse data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data from electronic health record or EHR, systems, to generate a patient risk score. KidneyIntelX has been granted designation by the United States Food and Drug Administration and is designed to help make significant improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.